placeholder image

P. Yan All authors

About

Publications While At HealthPartners

selected publications

Journal Article
  • DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide. 
  • Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial. 

    • Contact

    full name

  • P. Yan

    • Quick Info

    Publications

    Collaboration